ABVC BioPharma Inc.

AI Score

0

Unlock

0.70
0.01 (1.43%)
At close: Mar 03, 2025, 3:53 PM
0.67
-4.35%
After-hours: Mar 03, 2025, 04:00 PM EST

ABVC BioPharma Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02
PE Ratio -0.48 -1.21 -7.06 -29.8 -61.05 -5.66 -0.68 -4.78 -215.24 -1.87K -0.01 -18.33 -0.07 -0.07 -0.21 -27.4 -212.2 -29.31K -12.04K 33.51K -20.13 -33.2M
PEG Ratio 0.01 -0.17 0.66 -0.21 1.68 0.06 -0.00 -0.00 n/a 18.68 0.00 0.24 0.00 0.00 -0.00 -0.17 -0.01 6.1K 10.42 -334.86 -0.00 n/a
PS Ratio 32.99 20.41 238.71 653.61 342.18 3.34K 1.07K 673.55K 2.07K n/a 0.22 3.43K 28.04 9.46 -4.06 7.39K 23.69K n/a n/a 1.48K 37.36 66.41M
PB Ratio 0.60 6.39 9.60 91.82 -1.59K -4.04 2.06 178.39 238.95 4.28 -0.00 -11.93 -0.06 -0.05 -0.55 -149.61 3.4K 21.1K 5.29K 973.99 6.02 66.41M
P/FCF Ratio -1.18 -2.63 -11.15 -69.18 -76.6 -36.84 -2.03 -6.2 2.07K 111.90 -0.05 -20.98 -0.05 -0.13 -0.68 -72.69 -353.66 30.44K -17.43K -11.43K 1.44K -66.41M
P/OCF Ratio -1.19 -2.67 -11.18 -69.18 -76.6 -36.84 -2.03 -6.2 2.07K 111.90 -0.05 -21.42 -0.06 -0.13 -0.71 -79.4 -366.48 30.44K -17.43K -11.43K 1.44K -66.41M
OCF/S Ratio -27.79 -7.63 -21.35 -9.45 -4.47 -90.6 -526.75 -108.58K 1.00 n/a -4.85 -160.15 -499.43 -70.47 5.73 -93.1 -64.63 n/a n/a -0.13 0.03 -1
Debt / Equity Ratio 0.27 0.99 0.35 1.89 -30.33 -0.14 0.74 n/a 0.24 0.23 -0.61 -0.68 -0.79 -0.47 -0.42 -0.92 1.48 n/a n/a n/a 0.05 3.00
Quick Ratio 0.28 0.29 2.60 1.45 0.20 0.02 0.14 3.07 0.09 -0.02 0.00 0.02 0.06 0.01 0.00 0.36 0.96 1.66 23.29 27.61 3.98 n/a
Current Ratio 0.28 0.51 2.61 1.27 0.13 0.02 0.19 3.07 0.09 n/a 0.00 0.02 0.06 0.01 0.00 0.36 0.96 1.66 23.29 30.47 4.22 1.33
Asset Turnover 0.01 0.10 0.03 0.04 0.10 0.07 0.00 0.00 0.05 n/a 0.03 0.02 0.01 0.05 -0.52 0.02 0.03 n/a n/a 0.64 0.12 0.25
Interest Coverage -3.3 -51.42 -49.93 -21 -7.18 -8.94 -8.97 -442.21 n/a n/a -3.61 -13.03 -9.21 -7.7 -18.06 -3.77 -17.21 18.81 14.49 n/a -15.27 n/a
Return on Equity (ROE) -1.25 -5.26 -1.36 -3.08 26.05 0.71 -3.05 -37.31 -1.11 -0.00 0.12 0.65 0.83 0.63 2.58 5.46 -16.02 -0.72 -0.44 0.03 -0.3 -2
Return on Assets (ROA) -0.73 -1.66 -0.88 -0.91 -0.57 -42.6 -0.76 -25.42 -0.47 -0.00 -0.98 -3.54 -3.3 -6.47 -10 -4.51 -3.86 -0.29 -0.42 0.03 -0.23 -0.5
Return on Capital (ROIC) -0.96 -3.74 -1.13 -1.26 -30.44 0.25 -0.79 -37.2 -1.11 -0.00 0.09 0.70 1.29 0.56 2.44 4.32 -15.21 -0.76 -0.29 0.02 -0.28 -2
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin -98.15% 70.47% 98.57% 96.13% 97.13% -2.56K% 29.63% n/a 84.49% n/a 100.00% 100.00% 100.00% 100.00% 200.00% 100.00% 100.00% n/a n/a 43.66% -88.42% n/a
Net Profit Margin -6.9K% -1.68K% -3.38K% -2.19K% -560.51% -58.96K% -157.96K% -14.09M% -960.74% n/a -2.91K% -18.72K% -38.2K% -12.79K% 1.91K% -26.98K% -11.16K% n/a n/a 4.42% -185.54% -200%
Pretax Profit Margin -6.99K% -1.6K% -3.15K% -2.24K% -571.49% -58.93K% -219.97K% -14.08M% -960.74% n/a -2.91K% -17.53K% -31.78K% n/a 1.91K% -26.98K% n/a n/a n/a 4.42% -185.54% -200%
Operating Profit Margin -5.39K% -1.56K% -3.19K% -1.76K% -492.9% -20.03K% -62.32K% -14.05M% -960.74% n/a -2.28K% -20K% -59.18K% -11.32K% 1.81K% -21.34K% -10.6K% n/a n/a 3.49% -174.13% -200%
FCF Margin -2.79K% -775.23% -2.14K% -944.82% -446.69% -9.06K% -52.68K% -10.86M% 100.00% n/a -485.01% -16.36K% -51.25K% -7.12K% 594.51% -10.17K% -6.7K% n/a n/a -12.95% 2.60% -100%
EBITDA Margin -5.34K% -1.57K% -3.08K% -2.15K% -494.95% -39.4K% -125.04K% 1.75K% -960.74% n/a -1.97K% -15.42K% -30.71K% -11.02K% 1.79K% -21.17K% -10.57K% n/a n/a -25.39% -174.13% -200%